Watchlist

Watchlist
Acorda Therapeutics, Inc. (ACOR)
Acorda Therapeutics, Inc. (ACOR)
Institutional Top Ideas Series: Scopia Capital
In the last entry of this series, we took a look at top ideas from DAFNA Capital Management (whose performance practically tripled that of the IBB during the time frame we looked at). Going forward, I hope to continue to delve into the portfolios of successful hedge funds predominantly i…
Acorda to Present New Data For INBRIJA(TM) (levodopa inhalation powder) at 70th American Academy of Neurology Annual Meeting
Acorda Therapeutics, Inc. (Nasdaq: ACOR) will present new data for INBRIJA during four oral platform presentations at the upcoming American Academy of Neurology Annual Meeting in Los Angeles, taking place April 2127, 2018. INBRIJA is an investigational inhaled levodopa treatment for …
Acorda First Quarter Update: Webcast/Conference Call Scheduled for May 2, 2018
Acorda Therapeutics, Inc. (Nasdaq:ACOR) will host a conference call and webcast to report its first quarter 2018 financial results onWednesday, May 2 at 8:30 a.m. ET. To participate in the conference call, please dial (833) 236-2756 (domestic) or (647) 689-4181 (international) and …
Looking For Action? S&P 1500 Most Volatile Stocks
For traders with a short-term time horizon looking for big moves, we have updated our list of the S&P 1500 stocks trading above $10 that have the largest intraday high-low ranges (based on the average percent spread between the intraday high and low over the last 50 days). The stocks are g…
Acorda Files Marketing Authorization Application for INBRIJA(TM) (levodopa inhalation powder)
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for INBRIJA. Acorda is seeking marketing approval in the European Union for INBRIJA, an investigational inhaled levodopa treatment…
Key events next week - healthcare (continued #1)
Tuesday (3/20): Oppenheimer (continued). BioLineRx (NASDAQ: BLRX ); Aerie Pharmaceuticals (NASDAQ: AERI ); United Therapeutics (NASDAQ: UTHR );Addus HomeCare (NASDAQ: ADUS ); Centene (NYSE: CNC ); Quorum Health (NYSE: QHC ); Pfenex (NYSEMKT: PFNX ); SELLAS Life Sciences (NASDAQ: SLS…
Acorda Rallies Parkinson's Community in First-of-Its-Kind Initiative to Foster Better Conversations About Parkinson's Symptoms
New Initiative Live Well. Do Tell.Aims to Support People with Parkinsons Acorda Therapeutics, Inc. (Nasdaq:ACOR) today unveiled the Live Well. Do Tell. initiative for the Parkinsons disease community. Its goal is …
Acorda Therapeutics to Present at Oppenheimer Healthcare Conference
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Andrew Hindman, Acordas Chief Business Development Officer, will present at the Oppenheimer Healthcare Conference on Tuesday, March 20 at 11:30am. A live audio webcast of the presentation can be accessed under Investor E…
Acorda to Present at Cowen Health Care Conference
Acorda Therapeutics, Inc. (Nasdaq:ACOR) announced that Ron Cohen, M.D., Acorda's President and CEO, will present at the Cowen and Company 38 th Annual Health Care Conference on Tuesday, March 13 at 10:00am EST. A live audio webcast of the presentation can be accessed under Investor …
Acorda Therapeutics, Inc. (ACOR)